We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Terahertz Breast Imaging May Decrease Repeat Surgical Procedures

By HospiMedica staff writers
Posted on 05 May 2006
An exciting new technique that provides complete tumor removal during breast cancer excision has recently been developed.

Scientists utilized light waves in a newly discovered region of the electromagnetic spectrum--the terahertz region--to evaluate excised breast tissue and determine if the removed tissue margins were devoid of cancer, with good results. More...
This technology has the potential to eliminate the need for multiple surgeries and tissue samples to get clear surgical margins. The researchers published their study in the May 2006 issue of the journal Radiology.

"We found that terahertz light could reliably distinguish between normal breast tissue, tumor and even early-stage in situ cancers in excised tissue samples,” said Vincent P. Wallace, Ph.D., lead investigator at TeraView (Toronto; Canada), who worked with Addenbrooke's Hospital (Cambridge, UK), in performing the study.

At present, excised tissue samples must be sent for histopathologic examination, which characteristically takes several days. Therefore, surgeons cannot determine if all the tumor has been removed until quite a while after the surgical procedure has been completed, and frequently, repeat surgeries have to then be planned. For the first time, however, terahertz imaging has the potential to eliminate the need for additional procedures by allowing the surgeon to evaluate tissue samples during the first excision procedure.

Terahertz light is situated between the infrared and microwave regions of the electromagnetic spectrum. The investigators discovered that by placing a slice of excised breast tissue on a special quartz plate and exposing it to terahertz light, the light waves reflected from the tissue contained unique information about its characteristics. The researchers were able to differentiate both invasive and noninvasive breast carcinomas from normal tissue.

Twenty-two excised breast tissue samples were obtained from 22 women who underwent either wide local excision or mastectomy to remove breast cancer. All samples were first sliced and imaged with terahertz light, and then submitted for histopathologic analysis. Imaging took less than five minutes.

In breast cancer excision surgery, the goal is to remove the complete tumor with an adequate margin of normal tissue, while minimizing the amount of healthy tissue being removed. If a histopathologist analyzes the tissue and finds tumor at or near the edges, this indicates that there is a higher chance of cancer recurrence.



Related Links:
TeraView
Addenbrooke's Hospital

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mobile X-Ray System
K4W
Ultrasound Needle Guidance System
SonoSite L25
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.